Search

Timothy M. Johnson

Examiner (ID: 5718)

Most Active Art Unit
2723
Art Unit(s)
2723, 2625, 2616, 2623
Total Applications
329
Issued Applications
268
Pending Applications
23
Abandoned Applications
38

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 14963233 [patent_doc_number] => 20190309095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-10 [patent_title] => Synthetic Oligosaccharide Subunits Of The PSL Exopolysaccharide Of Pseudomonas Aeruginosa And Uses Thereof [patent_app_type] => utility [patent_app_number] => 16/219199 [patent_app_country] => US [patent_app_date] => 2018-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10220 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16219199 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/219199
Synthetic oligosaccharide subunits of the Psl exopolysaccharide of pseudomonas aeruginosa and uses thereof Dec 12, 2018 Issued
Array ( [id] => 16435655 [patent_doc_number] => 20200352980 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-12 [patent_title] => GLYCAN PREPARATIONS FOR THE TREATMENT OF INFECTION [patent_app_type] => utility [patent_app_number] => 16/761093 [patent_app_country] => US [patent_app_date] => 2018-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 62994 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -125 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16761093 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/761093
GLYCAN PREPARATIONS FOR THE TREATMENT OF INFECTION Nov 2, 2018 Abandoned
Array ( [id] => 15290845 [patent_doc_number] => 20190388558 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-26 [patent_title] => KARTOGENIN DERIVATIVE-CONTAINING POLYMERIC MICELLE, HYALURONIC ACID HYDROGEL, METHOD FOR PRODUCING THE SAME, AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/174902 [patent_app_country] => US [patent_app_date] => 2018-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7426 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16174902 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/174902
KARTOGENIN DERIVATIVE-CONTAINING POLYMERIC MICELLE, HYALURONIC ACID HYDROGEL, METHOD FOR PRODUCING THE SAME, AND USE THEREOF Oct 29, 2018 Abandoned
Array ( [id] => 16252109 [patent_doc_number] => 20200261483 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-08-20 [patent_title] => METHODS AND COMPOSITIONS FOR TREATING CYSTIC FIBROSIS [patent_app_type] => utility [patent_app_number] => 16/760317 [patent_app_country] => US [patent_app_date] => 2018-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6968 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -45 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16760317 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/760317
METHODS AND COMPOSITIONS FOR TREATING CYSTIC FIBROSIS Oct 28, 2018 Abandoned
Array ( [id] => 17952421 [patent_doc_number] => 11478494 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-10-25 [patent_title] => Methods and substances for prevention and treatment of neurodegenerative diseases [patent_app_type] => utility [patent_app_number] => 16/754426 [patent_app_country] => US [patent_app_date] => 2018-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8675 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16754426 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/754426
Methods and substances for prevention and treatment of neurodegenerative diseases Oct 14, 2018 Issued
Array ( [id] => 17207747 [patent_doc_number] => 11168106 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2021-11-09 [patent_title] => Synthesis and stabilization of nicotinamide ribose and its derivatives [patent_app_type] => utility [patent_app_number] => 16/160189 [patent_app_country] => US [patent_app_date] => 2018-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2333 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16160189 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/160189
Synthesis and stabilization of nicotinamide ribose and its derivatives Oct 14, 2018 Issued
Array ( [id] => 16025741 [patent_doc_number] => 10675270 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-06-09 [patent_title] => Chondroitin complexes for transcutaneous absorption [patent_app_type] => utility [patent_app_number] => 16/124269 [patent_app_country] => US [patent_app_date] => 2018-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5836 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16124269 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/124269
Chondroitin complexes for transcutaneous absorption Sep 6, 2018 Issued
Array ( [id] => 17349991 [patent_doc_number] => 11224609 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-01-18 [patent_title] => Mithramycin derivatives having increased selectivity and anti-cancer activity [patent_app_type] => utility [patent_app_number] => 16/122655 [patent_app_country] => US [patent_app_date] => 2018-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 18888 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16122655 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/122655
Mithramycin derivatives having increased selectivity and anti-cancer activity Sep 4, 2018 Issued
Array ( [id] => 16976142 [patent_doc_number] => 20210220379 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-22 [patent_title] => PERITONEAL SODIUM-GLUCOSE TRANSPORTER (SGLT) INHIBITORS FOR IMPROVEMENT OF PERITONEAL DIALYSIS [patent_app_type] => utility [patent_app_number] => 16/642989 [patent_app_country] => US [patent_app_date] => 2018-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11777 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16642989 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/642989
PERITONEAL SODIUM-GLUCOSE TRANSPORTER (SGLT) INHIBITORS FOR IMPROVEMENT OF PERITONEAL DIALYSIS Aug 29, 2018 Abandoned
Array ( [id] => 13837579 [patent_doc_number] => 20190022274 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-24 [patent_title] => FORMATION OF SEMI-PERMEABLE POROUS ARTIFICIAL SCAB [patent_app_type] => utility [patent_app_number] => 16/115874 [patent_app_country] => US [patent_app_date] => 2018-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1332 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16115874 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/115874
FORMATION OF SEMI-PERMEABLE POROUS ARTIFICIAL SCAB Aug 28, 2018 Abandoned
Array ( [id] => 15524703 [patent_doc_number] => 20200054657 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-02-20 [patent_title] => Compositions of Matter and Methoods to Treat Cancer [patent_app_type] => utility [patent_app_number] => 15/999295 [patent_app_country] => US [patent_app_date] => 2018-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12132 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15999295 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/999295
Compositions of Matter and Methoods to Treat Cancer Aug 19, 2018 Abandoned
Array ( [id] => 13826525 [patent_doc_number] => 20190016747 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-17 [patent_title] => PURIFIED REBAUDIOSIDE A [patent_app_type] => utility [patent_app_number] => 16/103818 [patent_app_country] => US [patent_app_date] => 2018-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24220 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16103818 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/103818
PURIFIED REBAUDIOSIDE A Aug 13, 2018 Abandoned
Array ( [id] => 13574983 [patent_doc_number] => 20180339040 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-11-29 [patent_title] => POLYSACCHARIDE SUITABLE TO MODULATE IMMUNE RESPONSE [patent_app_type] => utility [patent_app_number] => 16/054849 [patent_app_country] => US [patent_app_date] => 2018-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16920 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 175 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16054849 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/054849
Polysaccharide suitable to modulate immune response Aug 2, 2018 Issued
Array ( [id] => 15435347 [patent_doc_number] => 20200031857 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-30 [patent_title] => ANION EXCHANGE STATIONARY PHASES BASED ON A POLYALKYLPOLYAMINE POLYMER LAYER [patent_app_type] => utility [patent_app_number] => 16/049464 [patent_app_country] => US [patent_app_date] => 2018-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11682 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16049464 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/049464
ANION EXCHANGE STATIONARY PHASES BASED ON A POLYALKYLPOLYAMINE POLYMER LAYER Jul 29, 2018 Abandoned
Array ( [id] => 16868475 [patent_doc_number] => 20210161942 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-03 [patent_title] => GLYCAN COMPOSITIONS AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 16/630116 [patent_app_country] => US [patent_app_date] => 2018-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 63502 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -155 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16630116 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/630116
GLYCAN COMPOSITIONS AND METHODS OF USE Jul 12, 2018 Abandoned
Array ( [id] => 15960465 [patent_doc_number] => 20200163984 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-28 [patent_title] => USE OF ISOVALERYL SPIRAMYCIN I, II AND/OR III IN MANUFACTURING MEDICAMENT FOR TREATING AND/OR PREVENTING TUMOR, AND MEDICAMENT [patent_app_type] => utility [patent_app_number] => 16/627102 [patent_app_country] => US [patent_app_date] => 2018-07-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32047 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16627102 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/627102
USE OF ISOVALERYL SPIRAMYCIN I, II AND/OR III IN MANUFACTURING MEDICAMENT FOR TREATING AND/OR PREVENTING TUMOR, AND MEDICAMENT Jul 3, 2018 Abandoned
Array ( [id] => 17845124 [patent_doc_number] => 11434480 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-09-06 [patent_title] => Viral RNA extracting composition and viral RNA extracting method [patent_app_type] => utility [patent_app_number] => 16/343071 [patent_app_country] => US [patent_app_date] => 2018-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5829 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16343071 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/343071
Viral RNA extracting composition and viral RNA extracting method May 24, 2018 Issued
Array ( [id] => 15618823 [patent_doc_number] => 20200079816 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-03-12 [patent_title] => COBALAMIN DERIVATIVES AND THEIR USE FOR THE TREATMENT OF DISEASES CAUSED BY LACK OF VITAMIN B12 SUPPLY [patent_app_type] => utility [patent_app_number] => 16/615014 [patent_app_country] => US [patent_app_date] => 2018-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6887 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16615014 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/615014
Cobalamin derivatives and their use for the treatment of diseases caused by lack of vitamin B12 supply May 23, 2018 Issued
Array ( [id] => 16012899 [patent_doc_number] => 20200181292 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-11 [patent_title] => NOVEL WATER-SOLUBLE NATURAL POLYSACCHARIDE ANTIBACTERIAL MATERIAL AND PREPARATION METHOD THEREOF [patent_app_type] => utility [patent_app_number] => 16/629881 [patent_app_country] => US [patent_app_date] => 2018-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3539 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16629881 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/629881
NOVEL WATER-SOLUBLE NATURAL POLYSACCHARIDE ANTIBACTERIAL MATERIAL AND PREPARATION METHOD THEREOF May 23, 2018 Abandoned
Array ( [id] => 15553367 [patent_doc_number] => 20200061095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-02-27 [patent_title] => Compounds for the Treatment of Systemic Insulin Resistance Disorders and the Use Thereof [patent_app_type] => utility [patent_app_number] => 16/611620 [patent_app_country] => US [patent_app_date] => 2018-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35315 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -43 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16611620 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/611620
Compounds for the Treatment of Systemic Insulin Resistance Disorders and the Use Thereof May 10, 2018 Abandoned
Menu